PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB • US7437131094

66.45 USD
-0.7 (-1.04%)
At close: Feb 12, 2026
66.45 USD
0 (0%)
After Hours: 2/12/2026, 8:10:54 PM
Fundamental Rating

4

Taking everything into account, PRLB scores 4 out of 10 in our fundamental rating. PRLB was compared to 131 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year PRLB was profitable.
  • PRLB had a positive operating cash flow in the past year.
  • In multiple years PRLB reported negative net income over the last 5 years.
  • Of the past 5 years PRLB 4 years had a positive operating cash flow.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • PRLB has a Return On Assets (1.96%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 2.23%, PRLB is not doing good in the industry: 61.83% of the companies in the same industry are doing better.
  • PRLB has a worse Return On Invested Capital (2.11%) than 67.94% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PRLB is significantly below the industry average of 10.21%.
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • PRLB has a Profit Margin (2.86%) which is in line with its industry peers.
  • PRLB's Profit Margin has declined in the last couple of years.
  • The Operating Margin of PRLB (4.35%) is worse than 64.12% of its industry peers.
  • In the last couple of years the Operating Margin of PRLB has declined.
  • PRLB's Gross Margin of 44.12% is amongst the best of the industry. PRLB outperforms 83.97% of its industry peers.
  • PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

  • PRLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • PRLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 11.72 indicates that PRLB is not in any danger for bankruptcy at the moment.
  • PRLB has a Altman-Z score of 11.72. This is amongst the best in the industry. PRLB outperforms 94.66% of its industry peers.
  • PRLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 11.72
ROIC/WACC0.22
WACC9.6%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 3.24 indicates that PRLB has no problem at all paying its short term obligations.
  • PRLB has a Current ratio of 3.24. This is amongst the best in the industry. PRLB outperforms 80.15% of its industry peers.
  • A Quick Ratio of 3.04 indicates that PRLB has no problem at all paying its short term obligations.
  • The Quick ratio of PRLB (3.04) is better than 87.79% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 3.04
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

  • PRLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.23%.
  • PRLB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.99% yearly.
EPS 1Y (TTM)1.23%
EPS 3Y3.23%
EPS 5Y-6.99%
EPS Q2Q%15.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.23% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y2.56%
EPS Next 2Y9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.87%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 40.27 indicates a quite expensive valuation of PRLB.
  • Based on the Price/Earnings ratio, PRLB is valued a bit more expensive than the industry average as 64.12% of the companies are valued more cheaply.
  • PRLB is valuated rather expensively when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 39.27, PRLB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PRLB indicates a slightly more expensive valuation: PRLB is more expensive than 64.89% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.69. PRLB is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 40.27
Fwd PE 39.27
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • PRLB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PRLB is more expensive than 65.65% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PRLB is valued a bit cheaper than the industry average as 69.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.23
EV/EBITDA 25.23
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRLB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)15.75
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PROTO LABS INC

NYSE:PRLB (2/12/2026, 8:10:54 PM)

After market: 66.45 0 (0%)

66.45

-0.7 (-1.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-06
Earnings (Next)04-30
Inst Owners94.33%
Inst Owner Change-1.33%
Ins Owners1.08%
Ins Owner Change1.25%
Market Cap1.57B
Revenue(TTM)N/A
Net Income(TTM)14.84M
Analysts78.18
Price Target57.8 (-13.02%)
Short Float %1.95%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.68%
Min EPS beat(2)17.55%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)15.66%
Min EPS beat(4)10.87%
Max EPS beat(4)17.81%
EPS beat(8)8
Avg EPS beat(8)23.41%
EPS beat(12)12
Avg EPS beat(12)26.01%
EPS beat(16)15
Avg EPS beat(16)25.13%
Revenue beat(2)1
Avg Revenue beat(2)1.29%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)3.41%
Revenue beat(4)2
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)3.41%
Revenue beat(8)4
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)8
Avg Revenue beat(16)0.39%
PT rev (1m)0%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.37%
EPS NY rev (1m)0%
EPS NY rev (3m)6.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 40.27
Fwd PE 39.27
P/S 3.04
P/FCF 23.23
P/OCF 20.88
P/B 2.37
P/tB 4.24
EV/EBITDA 25.23
EPS(TTM)1.65
EY2.48%
EPS(NY)1.69
Fwd EY2.55%
FCF(TTM)2.86
FCFY4.3%
OCF(TTM)3.18
OCFY4.79%
SpS21.89
BVpS28.07
TBVpS15.68
PEG (NY)15.75
PEG (5Y)N/A
Graham Number32.28
Profitability
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROCE 3.28%
ROIC 2.11%
ROICexc 2.56%
ROICexgc 5.3%
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
FCFM 13.06%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexgc growth 3Y-8.13%
ROICexgc growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.08%
Cap/Sales 1.47%
Interest Coverage 250
Cash Conversion 132.03%
Profit Quality 456.43%
Current Ratio 3.24
Quick Ratio 3.04
Altman-Z 11.72
F-Score6
WACC9.6%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.23%
EPS 3Y3.23%
EPS 5Y-6.99%
EPS Q2Q%15.79%
EPS Next Y2.56%
EPS Next 2Y9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.11%
Revenue Next Year4.87%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.4%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year63.4%
EBIT Next 3Y26.27%
EBIT Next 5YN/A
FCF growth 1Y32.02%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y13.3%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%

PROTO LABS INC / PRLB FAQ

Can you provide the ChartMill fundamental rating for PROTO LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to PRLB.


What is the valuation status of PROTO LABS INC (PRLB) stock?

ChartMill assigns a valuation rating of 1 / 10 to PROTO LABS INC (PRLB). This can be considered as Overvalued.


What is the profitability of PRLB stock?

PROTO LABS INC (PRLB) has a profitability rating of 3 / 10.


What is the financial health of PROTO LABS INC (PRLB) stock?

The financial health rating of PROTO LABS INC (PRLB) is 8 / 10.


Can you provide the expected EPS growth for PRLB stock?

The Earnings per Share (EPS) of PROTO LABS INC (PRLB) is expected to grow by 2.56% in the next year.